Eloxx Pharmaceuticals Inc. – Credit Agreements Watch

from 10-K 5 pages Agreement Regarding Loan Conversions

from 10-K 24 pages Neither This Security Nor the Securities for Which This Security Is Exercisable Have Been Registered With the Securities and Exchange Commission or the Securities Commission of Any State in Reliance Upon an Exemption From Registration Under the Securities Act of 1933, as Amended (The “Securities Act”), And, Accordingly, May Not Be Offered or Sold Except Pursuant to an Effective Registration Statement Under the Securities Act or Pursuant to an Available Exemption From, or in a Transaction Not Subject To, the Registration Requirements of the Securities Act and in Accordance With Applicable State Securities Laws. This Security and the Securities Issuable Upon Exercise of This Security May Be Pledged in Connection With a Bona Fide Margin Account or Other Loan Secured by Such Securities. Pre-Funded Common Stock Purchase Warrant ELOXX Pharmaceuticals, Inc. Warrant Shares: [  ] Issue Date: January 9, 2024 Initial Exercise Date: January 9, 2024 Section 2. Exercise

from 10-K 92 pages Sixth Amendment to Loan and Security Agreement This Sixth Amendment to Loan and Security Agreement (This

from 10-K 88 pages Fifth Amendment to Loan and Security Agreement

from 10-Q 9 pages Third Amendment to Loan and Security Agreement

from 10-Q 9 pages Second Amendment to Loan and Security Agreement

from 10-Q 7 pages First Amendment to Loan and Security Agreement

from 10-K 6 pages First Amendment to Loan and Security Agreement

from 10-K 76 pages Loan and Security Agreement

from 10QSB ~5 pages Parenteau Loan Agreement

from 10QSB ~5 pages Amended South Edge Loan Agreement

from 10QSB ~5 pages Material contract